Oxford Biomedica plc (LON:OXB)
London · Delayed Price · Currency is GBP · Price in GBX 643.00
-10.00 (-1.53%)
Oct 10, 2025, 4:35 PM BST
Oxford Biomedica Market Cap
Oxford Biomedica has a market cap or net worth of 772.77 million as of October 10, 2025. Its market cap has increased by 95.36% in one year.
Market Cap
772.77M
Enterprise Value
824.32M
Revenue
151.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
643.00
Market Cap Chart
Since September 22, 1997, Oxford Biomedica's market cap has increased from 17.39M to 772.77M, an increase of 4,342.82%. That is a compound annual growth rate of 14.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 772.77M | 73.68% |
| Dec 31, 2024 | 444.94M | 108.92% |
| Dec 29, 2023 | 212.97M | -50.00% |
| Dec 30, 2022 | 425.96M | -59.79% |
| Dec 31, 2021 | 1.06B | 24.98% |
| Dec 31, 2020 | 847.63M | 71.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 200.66B |
| GSK plc | 65.98B |
| Haleon | 30.29B |
| Smith & Nephew | 11.51B |
| ConvaTec Group | 4.86B |
| Hikma Pharmaceuticals | 4.10B |
| HUTCHMED (China) | 1.99B |
| Genus | 1.75B |